Target intelligence / Profile preview

Transmembrane protein 14C (TMEM14C)

Target
TMEM14C
Molecular classification
Mitochondrial membrane transporter, Other (Transmembrane protein)
01

Overview

Transmembrane protein 14C (TMEM14C) is an inner mitochondrial membrane protein essential for terminal heme synthesis, particularly in the erythroid lineage. It facilitates the import of protoporphyrinogen IX, a crucial intermediate in the heme biosynthetic pathway, into the mitochondrial matrix. TMEM14C is highly conserved and enriched in hematopoietic tissues. Loss of TMEM14C function leads to a blockade in erythroid heme synthesis, accumulation of porphyrin precursors, maturation arrest of erythroid cells, and embryonic lethality due to profound anemia in animal models. Its absence is therefore implicated in certain forms of congenital anemia. There are currently no known drugs that directly interact with TMEM14C, nor is it established as a pharmacological target, but it is considered an essential component in heme metabolism[1][2][3][5]. Key supporting details: - TMEM14C is classified as a transporter protein located in the mitochondrial inner membrane[8]. - It is needed for normal heme biosynthesis, especially during erythropoiesis[2][1]. - TMEM14C gene defects result in failure of erythroid maturation and anemia due to the blockade of protoporphyrinogen IX import into mitochondria, precluding adequate heme production[1][5]. - Disease relevance is most established for hereditary anemias; cancer association is listed but not extensively validated[3]. - No drugs or direct targeting mechanisms are reported in current databases.

Other names
C6orf53HSPC194bA421M1.6NET26MSTP073
02

Biological functions

Heme biosynthesisErythrocyte differentiationMitochondrial transport
03

Disease associations

Anemia (specifically, congenital or sideroblastic anemia)Cancer (evidence for association with trachea adenoid cystic carcinoma)
04

Safety considerations

Deficiency or dysfunction causes accumulation of heme synthesis intermediates and severe anemia, but specific therapeutic safety challenges are not well described in the literature[1][3].

Beyond the preview

Go deeper on Transmembrane protein 14C (TMEM14C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 14C (TMEM14C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call